Utilizing Modelling & Simulation to Facilitate Advanced Process Control, Integration of Biopharma Upstream & Downstream Processes for Continuous Manufacturing
Time: 12:00 pm
day: Day Two Track B AM
• High precision and accuracy is required to break the industry 2-3 sigma level. Modelling
and simulation has been recognized as a key enabler to achieve the goals of continuous
manufacturing. Digital twin, the broad spectrum of modelling and simulation, is now being
strongly advocated by regulatory agencies such as EMA and FDA.
• In this presentation, Biogen will walk you through how to utilize robust modelling and
simulation to facilitate advanced process control and connection of upstream and
downstream processes for continuous manufacturing.